{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:19:06Z","timestamp":1790540346636,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Changes in lipid levels\/profiles can reflect health status and diseases. Urinary lipidomics, thus, has a great potential in clinical diagnostics\/prognostics. Previously, only chloroform and methanol were used for extracting lipids from the urine. The present study aimed to optimize lipid extraction and examine differential lipid classes obtained by various extraction protocols. Urine samples were collected from eight healthy individuals and then pooled. Lipids were extracted by six solvent protocols, including (i) chloroform\/methanol (1:1, v\/v), (ii) chloroform\/methanol (2:1, v\/v), (iii) hexane\/isopropanol (3:2, v\/v), (iv) chloroform, (v) diethyl ether, and (vi) hexane. Lipid profiles of the six extracts were acquired by MALDI-TOF mass spectrometry (MS) and some lipid classes were verified by LIFT-TOF\/TOF MS\/MS. The data revealed that phosphatidylglycerol (PG) and phosphatidylinositol (PI) could be detected by all six protocols. However, phosphatidylcholine (PC) and sphingomyelin (SM) were detectable only by protocols (i)\u2013(iv), whereas phosphatidylserine (PS) was detectable only by protocols (iii)\u2013(vi), and phosphatidylethanolamine (PE) was detectable only by protocols (v)\u2013(vi). In summary, we have demonstrated differential lipidome profiles yielded by different extraction protocols. These data can serve as an important source for selection of an appropriate extraction method for further highly focused studies on particular lipid classes in the human urine.<\/jats:p>","DOI":"10.1038\/srep33756","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T09:25:26Z","timestamp":1474363526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF\/TOF analyses"],"prefix":"10.1038","volume":"6","author":[{"given":"Phornpimon","family":"Tipthara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visith","family":"Thongboonkerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"BFsrep33756_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ndt\/gfp476","volume":"25","author":"V Thongboonkerd","year":"2010","unstructured":"Thongboonkerd, V. Current status of renal and urinary proteomics: ready for routine clinical application? Nephrol. Dial. Transplant. 25, 11\u201316 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFsrep33756_CR2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI105639","volume":"46","author":"S Klahr","year":"1967","unstructured":"Klahr, S., Tripathy, K. & Bolanos, O. Qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome. J Clin. Invest 46, 1475\u20131481 (1967).","journal-title":"J Clin. Invest"},{"key":"BFsrep33756_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","volume":"51","author":"M Fuller","year":"2005","unstructured":"Fuller, M. et al. Urinary lipid profiling for the identification of fabry hemizygotes and heterozygotes. Clin. Chem. 51, 688\u2013694 (2005).","journal-title":"Clin. Chem."},{"key":"BFsrep33756_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1006\/bbrc.1993.1814","volume":"194","author":"E Uyama","year":"1993","unstructured":"Uyama, E. et al. Abnormal excretion of urinary phospholipids and sulfatide in patients with mitochondrial encephalomyopathies. Biochem. Biophys. Res. Commun. 194, 266\u2013273 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep33756_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00240-010-0281-6","volume":"39","author":"C Boonla","year":"2011","unstructured":"Boonla, C., Youngjermchan, P., Pumpaisanchai, S., Tungsanga, K. & Tosukhowong, P. Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients. Urol. Res. 39, 9\u201319 (2011).","journal-title":"Urol. Res."},{"key":"BFsrep33756_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02556340","volume":"42","author":"SR Khan","year":"1988","unstructured":"Khan, S. R., Shevock, P. N. & Hackett, R. L. Presence of lipids in urinary stones: results of preliminary studies. Calcif. Tissue Int. 42, 91\u201396 (1988).","journal-title":"Calcif. Tissue Int."},{"key":"BFsrep33756_CR7","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1046\/j.1523-1755.2002.00676.x","volume":"62","author":"SR Khan","year":"2002","unstructured":"Khan, S. R., Glenton, P. A., Backov, R. & Talham, D. R. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int. 62, 2062\u20132072 (2002).","journal-title":"Kidney Int."},{"key":"BFsrep33756_CR8","first-page":"375","volume":"52","author":"C Josepovitz","year":"1985","unstructured":"Josepovitz, C., LeVine, R., Lane, B. & Kaloyanides, G. J. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat. Lab Invest 52, 375\u2013386 (1985).","journal-title":"Lab Invest"},{"key":"BFsrep33756_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.cell.2010.11.033","volume":"143","author":"MR Wenk","year":"2010","unstructured":"Wenk, M. R. Lipidomics: new tools and applications. Cell 143, 888\u2013895 (2010).","journal-title":"Cell"},{"key":"BFsrep33756_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrd1776","volume":"4","author":"MR Wenk","year":"2005","unstructured":"Wenk, M. R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594\u2013610 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFsrep33756_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/mas.10061","volume":"22","author":"M Pulfer","year":"2003","unstructured":"Pulfer, M. & Murphy, R. C. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22, 332\u2013364 (2003).","journal-title":"Mass Spectrom. Rev."},{"key":"BFsrep33756_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.plipres.2004.08.001","volume":"43","author":"J Schiller","year":"2004","unstructured":"Schiller, J. et al. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog. Lipid Res. 43, 449\u2013488 (2004).","journal-title":"Prog. Lipid Res."},{"key":"BFsrep33756_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-2275(20)43013-5","volume":"11","author":"RJ Desnick","year":"1970","unstructured":"Desnick, R. J., Sweeley, C. C. & Krivit, W. A method for the quantitative determination of neutral glycosphingolipids in urine sediment. J Lipid Res. 11, 31\u201337 (1970).","journal-title":"J Lipid Res."},{"key":"BFsrep33756_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/rcm.858","volume":"17","author":"KA Al Saad","year":"2003","unstructured":"Al Saad, K. A. et al. Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry of lipids: ionization and prompt fragmentation patterns. Rapid Commun. Mass Spectrom. 17, 87\u201396 (2003).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"BFsrep33756_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00216-003-2057-0","volume":"376","author":"D Suckau","year":"2003","unstructured":"Suckau, D. et al. A novel MALDI LIFT-TOF\/TOF mass spectrometer for proteomics. Anal. Bioanal. Chem. 376, 952\u2013965 (2003).","journal-title":"Anal. Bioanal. Chem."},{"key":"BFsrep33756_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/abio.2000.4926","volume":"289","author":"M Petkovic","year":"2001","unstructured":"Petkovic, M. et al. Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal. Biochem. 289, 202\u2013216 (2001).","journal-title":"Anal. Biochem."},{"key":"BFsrep33756_CR17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0022-2275(20)34196-1","volume":"42","author":"J Schiller","year":"2001","unstructured":"Schiller, J. et al. Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res. 42, 1501\u20131508 (2001).","journal-title":"J Lipid Res."},{"key":"BFsrep33756_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ab.2006.12.026","volume":"362","author":"RA Johanson","year":"2007","unstructured":"Johanson, R. A., Buccafusca, R., Quong, J. N., Shaw, M. A. & Berry, G. T. Phosphatidylcholine removal from brain lipid extracts expands lipid detection and enhances phosphoinositide quantification by matrix-assisted laser desorption\/ionization time-of-flight (MALDI-TOF) mass spectrometry. Anal. Biochem. 362, 155\u2013167 (2007).","journal-title":"Anal. Biochem."},{"key":"BFsrep33756_CR19","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1039\/b804715d","volume":"133","author":"H Kim","year":"2008","unstructured":"Kim, H., Ahn, E. & Moon, M. H. Profiling of human urinary phospholipids by nanoflow liquid chromatography\/tandem mass spectrometry. Analyst 133, 1656\u20131663 (2008).","journal-title":"Analyst"},{"key":"BFsrep33756_CR20","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1021\/pr070328s","volume":"6","author":"V Thongboonkerd","year":"2007","unstructured":"Thongboonkerd, V. Practical points in urinary proteomics. J Proteome. Res. 6, 3881\u20133890 (2007).","journal-title":"J Proteome. Res."},{"key":"BFsrep33756_CR21","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 51, 3299\u20133305 (2010).","journal-title":"J Lipid Res."},{"key":"BFsrep33756_CR22","doi-asserted-by":"publisher","first-page":"D527","DOI":"10.1093\/nar\/gkl838","volume":"35","author":"M Sud","year":"2007","unstructured":"Sud, M. et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 35, D527\u2013D532 (2007).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep33756_CR23","doi-asserted-by":"publisher","first-page":"W606","DOI":"10.1093\/nar\/gkm324","volume":"35","author":"E Fahy","year":"2007","unstructured":"Fahy, E., Sud, M., Cotter, D. & Subramaniam, S. LIPID MAPS online tools for lipid research. Nucleic Acids Res. 35, W606\u2013W612 (2007).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33756","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:40:28Z","timestamp":1672897228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep33756"],"URL":"https:\/\/doi.org\/10.1038\/srep33756","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]},"assertion":[{"value":"26 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33756"}}